These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 5562103
1. [Therapy of progressive muscular dystrophy]. Beckmann R. Med Klin; 1971 Aug 06; 66(32):1099. PubMed ID: 5562103 [No Abstract] [Full Text] [Related]
2. [Clinical aspects and therapy of muscular dystrophies]. Beckmann R. Internist (Berl); 1972 Mar 06; 13(3):108-17. PubMed ID: 4553893 [No Abstract] [Full Text] [Related]
3. [Therapeutic possibilities in progressive muscular dystrophy]. Beckmann R, von Osten V. Dtsch Med Wochenschr; 1966 Jan 21; 91(3):108-16. PubMed ID: 5901816 [No Abstract] [Full Text] [Related]
4. [The treatment of muscular dystrophy with the nucleoside-nucleotide mixture Laevadosine]. Radu H, Stenzel K, Migea S, Bordeianu L. Munch Med Wochenschr; 1967 Dec 22; 109(51):2702-5. PubMed ID: 4873261 [No Abstract] [Full Text] [Related]
5. [Experience with and considerations on therapy of progressive muscular dystrophies]. Beckmann R. Hippokrates; 1968 Dec 15; 39(23):876-88. PubMed ID: 5718770 [No Abstract] [Full Text] [Related]
6. [The treatment of progressive muscular dystrophy with nucleosides and nucleotides. Clinical and serologic findings (aldolase and creatinphosphokinase)]. Ceccarelli A, Leone P, Moretti A. Clin Pediatr (Bologna); 1967 Sep 15; 49(9):468-75. PubMed ID: 5608288 [No Abstract] [Full Text] [Related]
7. [Our experience in the treatment of progressive muscular dystrophy]. Buscaino GA. Acta Neurol (Napoli); 1966 Sep 15; 21(2):133-50. PubMed ID: 5961587 [No Abstract] [Full Text] [Related]
8. [New aspects of the management of progressive muscular dystrophy]. Tilscher H, Schenk S. Wien Med Wochenschr; 1967 Nov 04; 117(44):1000-2. PubMed ID: 5591872 [No Abstract] [Full Text] [Related]
9. [Duchenne muscular dystrophy. Effects of vitamin E administration on urinary luminescence]. Pizarro M, Lissi E, Reyes J, Holmgren J. Rev Med Chil; 1998 Oct 04; 126(10):1165-72. PubMed ID: 10030087 [Abstract] [Full Text] [Related]
10. [Therapy and macroergic phosphoric compounds in Duchenne's progressive muscular dystrophy]. Radu H, Stenzel K, Blücher G, Gödri I. Neurol Psihiatr Neurochir; 1969 Oct 04; 14(5):435-42. PubMed ID: 5380160 [No Abstract] [Full Text] [Related]
11. [Progressive muscular dystrophies and possibilities of their treatment]. Beckmann R, Teirich-Leube H. Ther Ggw; 1970 May 04; 109(5):648 passim. PubMed ID: 5422181 [No Abstract] [Full Text] [Related]
12. A study of electromyographic findings in patients with progressive muscular dystrophy during remetabolizing therapy. Buscaino GA, Caruso G. Acta Neurol (Napoli); 1966 May 04; 21(1):33-45. PubMed ID: 4385733 [No Abstract] [Full Text] [Related]
13. [Current status of experience and concepts concerning the therapy of progressive muscular dystrophies]. Beckmann R. Monatsschr Kinderheilkd (1902); 1968 Oct 04; 116(10):535-9. PubMed ID: 4889952 [No Abstract] [Full Text] [Related]
14. Treatment of muscular dystrophy. Fowler WM. Arch Phys Med Rehabil; 1973 Jun 04; 54(6):281-3. PubMed ID: 4708009 [No Abstract] [Full Text] [Related]
15. [Treatment of progressive muscular dystrophy]. Badalian LO, Dunaevskaia GN, Sitnikov VF. Zh Nevropatol Psikhiatr Im S S Korsakova; 1975 Jun 04; 75(9):1317-23. PubMed ID: 1080939 [Abstract] [Full Text] [Related]